Accelerating patient access to novel biologics using stable pool‐derived product for non‐clinical studies and single clone‐derived product for clinical studies
Trent P. Munro(The University of Queensland), Chetan T. Goudar(Amgen (United States)), Neil Soice(Amgen (United States)), Robert W. Hong(Amgen (United States)), Jennitte Stevens(Amgen (United States)), Lı Zhang(Sichuan Agricultural University), Hương Giang Lê(Gyeongsang National University), Kim Le(Amgen (United States)), Sabrina A. Benchaar(Amgen (United States))
Cited by 35
Related Papers
Multivariate analysis of cell culture bioprocess data—Lactate consumption as process indicator
|Journal of Biotechnology|2012|178
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
|The Lancet Infectious Diseases|2021|119
Mining manufacturing data for discovery of high productivity process characteristics
|Journal of Biotechnology|2010|93
Does foliar nutrient resorption regulate the coupled relationship between nitrogen and phosphorus in plant leaves in response to nitrogen deposition?
|The Science of The Total Environment|2018|69
Warming effects on C:N:P stoichiometry and nutrient limitation in terrestrial ecosystems
|Soil and Tillage Research|2023|51